Mirum Pharmaceuticals (MIRM) Other Working Capital Changes (2019 - 2026)

Mirum Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $6.6 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 1725.0% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $12.7 million (up 834.58% YoY), while the FY2025 annual figure was $5.7 million, up 278.04% from the prior year.
• Other Working Capital Changes was $6.6 million for Q1 2026 at Mirum Pharmaceuticals, down from $7.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $7.0 million in Q4 2025 to a low of -$2.7 million in Q3 2025.
• Historically, Other Working Capital Changes has averaged $972176.5 across 5 years, with a median of $49000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes tumbled 1176.0% in 2023, then surged 6975.51% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at $2.0 million in 2022, then plunged by 137.66% to -$760000.0 in 2023, then jumped by 149.47% to $376000.0 in 2024, then jumped by 1773.94% to $7.0 million in 2025, then declined by 5.9% to $6.6 million in 2026.
• The last three Other Working Capital Changes figures came in at $6.6 million (Q1 2026), $7.0 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.